Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (2) Birchmeier-Kohler, Carmen Prof. Dr. (1) Costanza, Mariantonia Dr. (1) Diecke, Sebastian Dr. (6) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hirsekorn, Antje (1) Kirchner, Marieluise Dr. (1) Kühn, Ralf Dr. (1) Lacadie, Scott Allen Dr. (1) Leutz, Achim Prof. Dr. (1) Müthel, Stefanie (1) Ofenbauer, Andreas Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (2) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (1) Tursun, Baris Dr. (1) Uyar, Bora Dr. (2) Vucicevic, Dubravka (1) Willnow, Thomas Prof. Dr. (1) (-) Hinze, Christian Dr. med. Dipl.-Math. (1) (-) Janz, Martin Dr. (3) (-) Mathas, Stephan Dr. (3) (-) Zauber, Henrik Dr. (1) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (4) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (4) Genom-Editierung & Krankheitsmodelle (1) Integrative Vaskuläre Biologie (1) Kardiale MRT (4) Magnetic Resonance (4) Molekulare Herz- Kreislaufforschung (1) Myologie (1) (-) Pluripotent Stem Cells (1) Proteom Dynamik (3) Proteomics (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (1) 1999 (2) 2000 (2) 2001 (1) 2002 (6) 2003 (3) 2004 (3) (-) 2005 (3) 2007 (4) 2008 (4) 2009 (4) 2010 (3) 2011 (4) 2012 (2) 2013 (3) 2014 (2) 2016 (3) (-) 2018 (2) 2019 (2) 2020 (6) 2021 (3) 2022 (8) 2023 (10) 2024 (2) 5 Ergebnisse: Active Filter: Hinze, Christian Dr. med. Dipl.-Math.Janz, Martin Dr.Mathas, Stephan Dr.Zauber, Henrik Dr.Biologie maligner LymphomePluripotent Stem Cells20052018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken 01. Januar 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken 20. September 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach 01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
01. Januar 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
20. September 2018 / Cell Mutations in disordered regions can cause disease by creating dileucine motifs K. Meyer M. Kirchner B. Uyar J.Y. Cheng G. Russo L.R. Hernandez-Miranda A. Szymborska H. Zauber I.M. Rudolph T.E. Willnow A. Akalin V. Haucke H. Gerhardt C. Birchmeier R. Kühn M. Krauss S. Diecke J.M. Pascual M. Selbach
01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas